This pharmaceutical company is a leading exporter, manufacturing over 100 products across a variety of therapeutic areas including antibiotics, antidiabetics, cardiovascular, central nervous system, pain management, and general medicine. They specialize in tablets, capsules, oral suspensions, and solutions. Their production facilities, located in the EU and Asia-Pacific regions, are GMP certified and adhere to international quality guidelines. The company has a strong focus on environmental responsibility, implementing measures to minimize pollution and waste during manufacturing processes. They also offer contract manufacturing services to other pharmaceutical companies globally.
Propranolol is a beta-blocker class medication primarily used to treat high blood pressure, performance anxiety, various types of irregular heart rate, thyrotoxicosis, capillary hemangiomas, and tremors. Suppliers market the drug as 50mg/5ml, 40mg/5ml, 10mg/5ml, and 5mg/5ml oral solution, as well as in the form of 10mg and 40mg propranolol tablets.
Propranolol was originally introduced into the market by manufacturer ICI pharmaceuticals (now a subsidiary of AstraZeneca). Currently, numerous manufacturing companies market both trade name and generic formulations of propranolol worldwide. Over 18 million prescriptions of the drug are registered annually in the U.S. alone, and the World Health Organization has included it in its list of Essential Medicines.
Buyers are advised that online sellers may attempt to market fraudulent versions of the generic drug, whereas Pipeline Pharma, through its pre-auditing and quality control procedures ensures that only verified manufacturers and wholesalers enter our online marketplace, offering you a risk-free B2B pharmaceutical sales platform.
The main alternatives to propranolol for the treatment of high blood pressure include other beta-blocker class drugs, such as bisoprolol, nebivolol, carvedilol, and others.
The retail prices for 30 (40mg) propranolol tablets are around 6.00 EUR.